Rifaximin
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01220 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 68 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | oral candidiasis | KG + DL |
| 2 | commissural lip fistula | KG + DL |
| 3 | osteoradionecrosis of the mandible | KG + DL |
| 4 | burning mouth syndrome | KG + DL |
| 5 | oral leukoedema | KG + DL |
| 6 | candidiasis | KG + DL |
| 7 | closed-angle glaucoma | KG + DL |
| 8 | neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter | KG + DL |
| 9 | HIV infectious disease | KG + DL |
| 10 | opiate dependence | KG + DL |
| 11 | Ledderhose disease | KG + DL |
| 12 | simian immunodeficiency virus infection | KG + DL |
| 13 | feline acquired immunodeficiency syndrome | KG + DL |
| 14 | palmar fibromatosis | KG + DL |
| 15 | infantile digital fibromatosis | KG + DL |
| 16 | arteriosclerotic retinopathy | KG + DL |
| 17 | retinal microaneurysm | KG + DL |
| 18 | vertebral artery occlusion | KG + DL |
| 19 | chronic hepatitis C virus infection | KG + DL |
| 20 | retinal artery occlusion | KG + DL |
| 21 | retinal telangiectasia | KG + DL |
| 22 | penile fibromatosis | KG + DL |
| 23 | lingual-facial-buccal dyskinesia | KG + DL |
| 24 | salivary gland disease | KG + DL |
| 25 | arteriosclerosis disorder | KG + DL |
| 26 | gastroduodenitis | KG + DL |
| 27 | tongue disease | KG + DL |
| 28 | coronary atherosclerosis | KG + DL |
| 29 | hepatitis B virus infection | KG + DL |
| 30 | chronic tic disorder | KG + DL |
| 31 | generalized atherosclerosis | KG + DL |
| 32 | cerebral atherosclerosis | KG + DL |
| 33 | psychogenic movement disorders | KG + DL |
| 34 | multiple endocrine neoplasia | KG + DL |
| 35 | extrapyramidal and movement disease | KG + DL |
| 36 | benign shuddering attacks | KG + DL |
| 37 | Reye syndrome | KG + DL |
| 38 | diarrheal disease | KG + DL |
| 39 | hydrophthalmos | KG + DL |
| 40 | benign paroxysmal tonic upgaze of childhood with ataxia | KG + DL |
| 41 | primary orthostatic tremor | KG + DL |
| 42 | acute intermittent porphyria | KG + DL |
| 43 | tremor-nystagmus-duodenal ulcer syndrome | KG + DL |
| 44 | hepatitis C virus infection | KG + DL |
| 45 | congenital glaucoma | KG + DL |
| 46 | familial Dupuytren contracture | KG + DL |
| 47 | drug-induced dyskinesia | KG + DL |
| 48 | hepatitis E virus infection | KG + DL |
| 49 | distal myopathy, Tateyama type | KG + DL |
| 50 | peptic ulcer disease | KG + DL |
(Showing top 50 of 68 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.